Safety of rituximab in children with auto-immune diseases by Bader-Meunier B, Quartier P, Wouters C

Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients by Bader-Meunier B, Wouters C, Lambot K, De Somer L

Pediatric systemic lupus erythematosus and human parvovirus B19 infection by Quartier P, Salomon R, Sauvion S, Bélien-Pallet V, Bader-Meunier B

Diversity in clinical manifestations of autoinflammatory syndromes by Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Neven B, Boiu S, Quartier P

Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus? by Fischbac M, Bérard E, Decramer S, Ranchin B, Bader-Meunier B, Jurado C, Saint-Marcoux F

Inflammatory arthritis associated with inflammatory bowel disease in children by Desgranges M, Ruemmele FM, Duquesnes A, Ginies JL, Goulet O, Quartier P, Bader-Meunier B

Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ? by Brousse N, Brochard K, de Saint Basile G, Janssen CEI, Fraitag S, Bader-Meunier B, Bodemer C, Wouters C

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... by Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients by Takada H, Nishikomori R, Imagawa T, Lheritier K, Preiss R, Patel N, Gattorno M, Kuemmerle-Deschner J, Hachulla P, Bader-Meunier B, Heike T, Hara T, Yokota S

International PFAPA syndrome registry: cohort of 214 patients by Hofer MF, Pillet P, Berg S, Brik R, Dolezalova P, Kone-Paut I, Anton J, Touitou I, Bader-Meunier B, Kaiser D, Rigante D, Duquesne A, Wouters C, Gattorno M

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations. by Rieux-Laucat, F, Blachère, S, Danielan, S, De Villartay, J, Oleastro, M, Solary, E, Bader-Meunier, B, Arkwright, P, Pondaré, C, Bernaudin, F, Chapel, H, Nielsen, S, Berrah, M, Fischer, A, Le Deist, F

Creation of a cohort of French patients with chronic recurrent multifocal osteitis : preliminary results by Lemelle I, Duquesne A, Despert V, Jean S, Desjonquères M, Wouters C, Mouy R, Bader-Meunier B, Lacassagne S, Faye A, Kettani S, Lorrot M, Dumitrescu MA, Wipff J, Pillet P, Grall-Lerosey M, Quartier P, Job-Deslandre C

Janus kinase inhibition for autoinflammation in DNASE2 deficiency by Hong, Y, Capitani, M, Murphy, C, Pandey, S, Cavounidis, A, Takeshita, H, Nanthapisal, S, Yasuda, T, Bader-Meunier, B, McCreary, D, Omoyinmi, E, Rao, A, Booth, C, Gilmour, K, Sebire, N, Shah, N, Klein, N, Bullock, A, Eleftheriou, D, Uhlig, H, Brogan, P